1. Adams, R. H., Wilkinson, G. A., Weiss, C., Diella, F., Gale, N. W., Deutsch, U., Risau, W. and Klein, R. (1999). Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev.3, 295-306.
2. Adams, R. H., Diella, F., Hennig, S., Helmbacher, F., Deutsch,U. and Klein, R. (2001). The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell104, 57-69.
3. Bader, B. L., Rayburn, H., Crowley, D. and Hynes, R. O.(1998). Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.Cell95, 507-519.
4. Beckmann, M. P., Cerretti, D. P., Baum, P., Vanden Bos, T.,James, L., Farrah, T., Kozlosky, C., Hollingsworth, T., Shilling, H.,Maraskovsky, E. et al. (1994). Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J.15, 3757-3762.
5. Brooks, P. C., Clark, R. A. and Cheresh, D. A.(1994). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science264, 569-571.